Vaccines for gonorrhea: Can we rise to the challenge?

Frontiers in Microbiology

Volumn 2, Issue JUNE, 2011, Pages

  Zhu, Weiyan ^a   Chen, Ching Ju ^b   Thomas, Christopher E ^a   Anderson, James E ^a   Jerse, Ann E ^a,c   Sparling, P Frederick ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Immune responses; Mouse models; Neisseria gonorrhoeae; Outer membranes; Recombinant proteins; Vaccines; Viral replicon particles

Indexed keywords

EID: 80052691653     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00124     Document Type: Article

References (116)

1. Arko, R. J., Duncan, W. P., Brown, W. J., Peacock, W. L., and Tomizawa, T. (1976). Immunity in infection with Neisseria gonorrhoeae: duration and serological response in the chimpanzee. J. Infect. Dis. 133, 441-447.
2. Beerink, P. T., and Granoff, D. M. (2008). Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines. Infect. Immun. 76, 2568-2575.
3. Blake, M. S., and Wetzler, L. M. (1995). Vaccines for gonorrhea: where are we on the curve? Trends Microbiol. 3, 469-474.
4. Blake, M. S., Wetzler, L. M., Gotschlich, E. C., and Rice, P. A. (1989). Protein III structure, function, and genetics. Clin. Microbiol. Rev. 2S, S60-S63.
5. Boslego, J. W., Tramont, E. C., Chung, R. C., Mcchesney, D. G., Ciak, J., Sadoff, J. C., Piziak, M.V., Brown,J. D., Brinton, C. C. J., Wood, S. W., and Bryan, J. R. (1991). Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 9, 154-162.
6. Boulton, I. C., and Gray-Owen, S. D. (2002). Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat. Immunol. 3, 229-236.
7. Brinton, C. C., Wood, S. W., Brown, A., Labik, A. M., Bryan, J. R., Lee, S. W., Polen, S. E., Tramont, E. C., Sadoff, J., and Zollinger, W. (1982). "The development of a Neisserial pilus vaccine for gonorrhea and meningococcal meningitis," in Seminars in Infectious Diseases, Vol. IV: Bacterial Vaccines, eds J. B. Robbins, J. C. Hill, and J. C. Sadoff (New York, NY: Thieme-Stratton), 140-159.
8. Brooks, G. F., and Ingwer, I. (1978). Studies on the relationships between serum bactericidal activity and uncomplicated genital infections due to Neisseria gonorrhoeae. J. Infect. Dis. 138, 333-339.
9. Buchanan, T. M., Eschenbach, D. A., Knapp, J. S., and Holmes, K. K. (1980). Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type. Am. J. Obstet. Gynecol. 138, 978-980.
10. Butler, D. (2010). Vaccine offers meningitis hope. Nature 468, 143.
11. Butt, N. J., Virji, M., Vayreda, F., Lambden, P. R., and Heckels, J. E. (1990). Gonococcal outer membrane-protein P1B: comparative sequence analysis and localization of epitopes which are recognized by type-specific and crossreacting monoclonal antibodies. J. Gen. Microbiol. 136, 2165-2172.
12. Carroll, T. D., Matzinger, S. R., Barro, M., Fritts, L., McChesney, M. B., Miller, C. J., and Johnston, R. E. (2011). Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of FluzoneR in rhesus macaques. Vaccine 931-940.
13. Centers for Disease Control. (2010). Sexually transmitted diseases treatment guidelines. Morbidity and Mortality Weekly Report 59, December 17, 1-114.
14. Chisholm, S. A., Mouton, J. W., Lewis, D. A., Nichols, T., Ison, C. A., and Livermore, D. M. (2010). Cephalosporin creep among gonococci: time for a pharmacodynamic rethink? J. Antimicrob. Chemother. 65, 2141-2148.
15. Cole, J. G., Fulcher, N. B., and Jerse, A. E. (2010). Opacity proteins increase fitness in the female genital tract due to a factor under ovarian control. Infect. Immun. 78, 1629-1641.
16. Cole, J. G., and Jerse, A. E. (2009). Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops. PLoS ONE 4, e8108. doi: 10.1371/journal. pone.0008108
17. Comanducci, M., Bambini, S., Brunelli, B., Adu-Bobie, J.,Aricò, B.,Capecchi, B., Giuliani, M. M., Masignani, V., Santini,L., Savino, S., Granoff, D. M., Caugant, D. A., Pizza, M., Rappuoli, R., and Mora, M. (2002). NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195, 1445-1454.
18. Conference Report. (2010). Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads. Vaccine 28, 4539-4547.
19. Cornelissen, C. N. (2008). Identification and characterization of gonococcal iron transport systems as potential vaccine antigens. Future Microbiol. 3, 287-298.
20. Cornelissen, C. N., Kelley, M., Hobbs, M. M., Anderson, J. E., Cannon, J. G., Cohen, M. S., and Sparling, P. F. (1998). The gonococcal transferrin receptor is required for human infection. Mol. Microbiol. 27, 611-616.
21. Criss, A. K., Katz, B. Z., and Seifert, H. S. (2009). Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leukocytes. Cell. Microbiol. 11, 1074-1087.
22. Criss, A. K., Kline, K. A., and Seifert, H. S. (2005). The frequency and rate of pilin antigenic variation in Neisseria gonorrhoeae. Mol. Microbiol. 58, 510-519.
23. Criss, A. K., and Seifert, H. S. (2008). Neisseria gonorrhoeae suppresses the oxidative burst of human polymorphonuclear leukocytes. Cell. Microbiol. 10, 2257-2270.
24. Davis, N. L., Brown, K. W., and Johnston, R. E. (1996). A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Virol. 70, 3781- 3787.
25. Denton, P. W., and Garcia, J. V. (2009). Novel humanized murine models for HIV research. Curr. HIV/AIDS Rep. 6, 13-19.
26. Donnelly, J., Medini, D., Boccadifuoco, G., Biolchi, A., Ward, J., Frasch, C., Moxon, E. R., Stella, M., Comanducci, M., Bambini, S., Muzzi, A., Andrews, W., Chen, J., Santos, G., Santini, L., Boucher, P., Serruto, D., Pizza, M., Rappuoli, R., and Giuliani, M. M. (2010). Qualitative and quantitative assessment of meningococcal antigens to evaluate potential strain coverage of protein-based vaccines. Proc. Natl. Acad. Sci. 107, 19490-19495.
27. Edwards, J. L., and Apicella, M. A. (2004). The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin. Microbiol. Rev. 17, 965-981.
28. Edwards, J. L., Brown, E. J., Uk-Nham, S., Cannon, J. G., Blake, M. S., and Apicella, M. A. (2002). A cooperative interaction between Neisseria gonorrhoeae and complement receptor 3 mediates infection of primary cervical epithelial cells. Cell. Microbiol. 4, 571-584.
29. Elkins, C., Carbonetti, N. H., Varela, V. A., Stirewalt, D., Klapper, D. G., and Sparling, P. F. (1992). Antibodies to N terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol. Microbiol. 6, 2617-2630.
30. Faruki, H., Kohmescher, R. N., McKinney, W. P., and Sparling, P. F. (1985). A community-based outbreak of a penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N. Engl. J. Med. 313, 607-611.
31. Feinen, B., Jerse, A. E., Gaffen, S. L., and Russel, M. W. (2010). Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol. 3, 312-321.
32. Findlow, J., Borrow, R., Snape, M. D., Dawson, T., Holland, A., John, T. M., Evans, A., Telford, K. L., Ypma, E., Toneatto, D., Oster, P., Miller, E., and Pollard, A. J. (2010). Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroupB vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 51, 1127-1137.
33. Fleming, D. T., and Wasserheit, J. N. (1999). From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75,3-17.
34. Fox, K.K. Thomas J.C., Weiner D. H., Davis, R. H., Sparling, P. F., and Cohen, M. S. (1999). Longitudinal evaluation of serovarspecific immunity to Neisseria gonorrhoeae. Am. J. Epidemiol. 149, 353-358.
35. Frasch, C. A., Borrow, R., and Donnelly, J. (2009). Bactericidal antibody is the immunological surrogate of protection against meningococcal disease. Vaccine 27S, B112-B116.
36. Goldschneider I., Gotschlich E. C., and Artenstein, M. S. (1969a). Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129, 1307-1326.
37. Goldschneider I., Gotschlich E. C., and Artenstein, M. S. (1969b). Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129, 1327-1348.
38. Golparian, D., Hellmark, B., Fredlund, H., and Unemo, M. (2010). Emergence, spread, and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex. Transm. Infect. 86, 454-460.
39. Granoff, D. (2009). Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine 27S, B117-B125.
40. Granoff, D. (2010). Review of meningococcal group B vaccines. Clin. Infect. Dis. 50S, S54-S65.
41. Greenberg, L. (1975). Field trials of a gonococcal vaccine. J. Reprod. Med. 14, 34-36.
42. Greenberg, L., Diena, B. B., Ashtron, F. A., Wallace, R., Kenney, C. P., Znamirowski, R., Ferrari, H., and Atkinson,J. (1974). Gonococcal vaccine studies in Inuvik. Can. J. Public Health 65, 29-33.
43. Gu, A., Zhang, Z., Chang, N., Tsark, W., and Shively, J. E. (2010). Generation of human CEACAM1 transgenic mice and binding of Opa protein to their neutrophils. PLoS ONE 5, e10067. doi: 10.1371/journal. pone.0010067
44. Gulati, S., McQuillen, D. P., Mandrell, R. E., Jani, D. B., and Rice, P. A. (1996). Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope, 2C7, widely expressed in vivo with no immunochemical similarity human glycosphingolipids. J. Infect. Dis. 174, 1223-1237.
45. Gwinn, W. M., Kirwan, S. M., Wang, S. H., Ashcraft, K. A., Sparks, N. L., Doil, C. R., Tlusty, T. G., Casey, L. S., Hollingshead, S. K., Briles, D. E., Dondero, R. S., Hickey, A. J., Foster, W. M.,and Staats,H.F. (2010). Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1. Vaccine 28, 6901-6914.
46. Handsfield, H. H., Lipman, T. O., Harnish, J. P., Tronca, E., and Holmes, K. K. (1974). Asymptomatic gonorrhea in men. Diagnosis natural course, prevalence and significance. N. Engl. J. Med. 290, 117-123.
47. Heckels, J. E., Fletcher, J. N., and Virji, M. (1989). The potential protective effect of immunization with outer membrane protein 1 from Neisseria gonorrhoeae. J. Gen. Microbiol. 135, 2269-2276.
48. Hedges, S. R., Mayo, M. S., Mestecky, J., Hook, E. W. III, and Russell, M. W. (1999). Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect. Immun. 67, 3937-3946.
49. Hedges, S. R., Sibley, D. A., Mayo, M. S., Hook, E. W., and Russell, M. W. (1998). Cytokine and antibody responses in women infected with Neisseria gonorhoeae: effects of concomitant infections. J. Infect. Dis. 178, 742-751.
50. Hill, J. (1942). Experimental infection with Neisseria gonorrhoeae. Am. J. Syph. Gonorrhea Vener. Dis. 27, 733-771.
51. Hobbs, M. M., Alcorn, T. M., Davis, R. H., Fischer, W., Thomas, J. C., Martin, I., Ison, C., Sparling, P. F., and Cohen, M. S. (1999). Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J. Infect. Dis. 179, 371-381.
52. Hubby, B., Talarico, T., Maughan, K. W., Reap, E. A., Berglund, P., Kamrud, K. L., Copp, L., Lewis, W., Cecil, C., Norberg, P., Wagner, J., Watson, A., Negri, S., Burnett, B. K., Graham, A., Smith, J. F., and Chulay, J. D. (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.Vaccine 25, 8180-8189.
53. Jarva, H., Ngampasutadol, J., Ram, S., Rice, P. A., Villoutreix, B. O., and Blom, A. M. (2007). Molecular characterization of the interaction between porins of Neisseria gonorrhoeae and C4b-binding protein. J. Immunol. 179, 540-547.
54. Jerse, A. E. (1999). Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67, 5699-5708.
55. Jerse, A. E., Cohen, M. S., Drown, P. M., Whicker, L. G., Isbey, S. F., Seifert, H. S., and Cannon, J. G. (1994). Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179, 911-920.
56. Kasper, D. L., Rice, P. A., and McCormick, W. M. (1977). Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J. Infect. Dis. 135, 243-251.
57. Keiser, P. B., Gibbs, B. T., Coster, T. S., Moran, E. E., Stoddard, M. B., Labrie, J. E. III, Schmiel, D. H., Pinto, V., Chen, P., and Zollinger, W. D. (2010). A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. Vaccine 28, 6970-6976.
58. Koeberling, O., Giuntini, S., Seubert, A., and Granoff, D. M. (2009). Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2. Clin. Vaccine Immunol. 16, 156-162.
59. Kozjak-Pavlovic, V., Dian-Lothrop, E. A., Meincke, M., Kepp, O., Ross, K., Rajalingam, K. Harsman, A., Hauf, E., Brinkmann, V., Gunther, D., Herrmann, I., Hurwitz, R., Rassow, J., Wagner, R., and Rudel, T. (2009). Bacterial porin disrupts mitochondrial membrane potential and sensitizes host cells to apoptosis. PLoS Pathog. 5, e1000629. doi: 10.1371/journal.ppat.1000629
60. Kraus, S. J., Brown, J. W., and Arko, R. J. (1975). Acquired and natural immunity to gonococcal infection in chimpanzees. J. Clin. Invest. 55, 1349-1356.
61. Lee, H. S., Ostrowski, M. A., and Gray-Owen, S. D. (2008). CEACAM1 dynamics during Neisseria gonorrhoeae suppression of CD4+ T lymphocyte activation. J. Immunol. 180, 6827-6835.
62. Lewis, D. A. (2010). The gonococcus fights back: is this time a knock-out? Sex. Transm. Infect. 86, 415-421.
63. Lewis, L. A., Ngampasutadol, J., Wallace, P., Reid, J. E., Vogel, U., and Ram, S. (2010). the meningococcal vaccine candidate neisserial surface proteinA (NspA). binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog. 6, e1001027. doi: 10.1371/journal.ppat.1001027
64. Lewis, L. A., Ram, S., Prasad, A., Gulati, S., Getzlaff, S., Blom, A. M., Vogel, U., and Rice, P. A. (2008). Defining targets for complement components C4b and C3b on the pathogenic neisseriae. Infect. Immun. 76, 339-350.
65. Li, S., Guo, X., Gong, X., Xu, M., Yan, J., Huang, Y., and Ren, Z. (2010). Bovine prolactin promotes the expression of human transferrin in the milk of transgenic mice. Biotechnol. Lett. 32, 787-793.
66. Lo, J. Y., Ho, K. M., Leung, A. O., Tiu, F. S., Tsang, G. K., Lo, A. C., and Tapsall, J. W. (2008). Cefibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Antimicrob. Agents Chemother. 52, 3564-3567.
67. Madico, G., Ngampasutadol, J., Gulati, S., Vogel, U., Rice, P. A., and Ram, S. (2007). Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin. J. Immunol. 178, 4489-4497.
68. Maiden, M. C., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'aldeen, D. A., Crook, D. W.,Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., Maclennan, J., Cameron, J. C., and Stuart, J. M. (2008). Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 197, 737-743.
69. Massari, P., Ram, S., Macleod, H., and Wetzler, L. M. (2003). The role of porins in neisserial pathogenesis and immunity. Trends Microbiol. 11, 87-93.
70. Matsuka, Y. V., Dilts, D. A., Hoiseth, S., and Arumugham, R. (1998). Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae. J. Protein Chem. 17, 719-728.
71. McChesney, D., Tramont, E. C., Boslego, J. W., Ciak, J. Sadoff, J. C., and Brinton, C. C. (1982). Genital antibody response to a parenteral gonococcal pilus vaccine. Infect. Immun. 36, 1006-1012.
72. Miettinen, SA., Hakkarainen, K.,Gronroos, P., Heinonen, P., Teisala, K., Aine, R., Sillantaka, I., Saarenmaa, K., Lehtinen, M., Punnonen, R., and Paavonen, J. (1989). Class specific antibody response to gonococcal infection. J. Clin. Pathol. 42, 72-76.
73. Nagashi, T., Chen, Z., Chen, L., Iijima, H., Nakajima, A., and Blumberg, R. S. (2008). CEACAM1 and the regulation of mucosal inflammation. Mucosal Immunol. 1(Suppl. 1), S39-S42.
74. Newman, L. M., Moran, J. S., and Workowski, K. A. (2007). Update on the management of gonorrhea in adults in the United States. Clin. Infect. Dis. 44S, S84-S101.
75. Ngampasutadol, J., Ram, S., Blom, A. M., Jarva, H., Jerse, A. E., Lien, E., Goguen, J., Gulati, S., and Rice, P. A. (2005). Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc. Natl. Acad. Sci. 102, 17142-17147.
76. Ngampasutadol, J., Ram, S., Gulati, S., Agarwal, S, Li, C., Visintin, A., Monks, B., Madico, G., and Rice, P. A. (2008). Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J. Immunol. 180, 3426-3435.
77. Ngampasutadol, J., Rice, P. A., Walsh, M. T., and Gulati, S. (2006). Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function. Vaccine 24, 157-170.
78. Pantelic, M.,Kim,Y.J.,Bolland,S., Chen, I., Shively, J., and Chen, T. (2005). Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infect. Immun. 73, 4171-4179.
79. Plante, M., Jerse, A. E., Hamel, J., Couture, F., Rioux, C. R., Brodeur, B. R., and Martin, D. (2000). Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoae. J. Infect. Dis. 182, 848-855.
80. Plummer, F. A., Simonsen, N. J., Chubb, H., Slaney, L., Kimata, J., Bosire, M., Ndinya-Achola, J. O., and Ngugi, E. N. (1989). Epidemiologic evidence for the development of serovarspecific immunity after gonococcal infection. J. Clin. Invest. 83, 1472-1476.
81. Price, G. A., Masri, H. P., Hollander, A. M., Russell, M. W., and Cornelissen, C. N. (2007). Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice. Vaccine 25, 7247-7260.
82. Price, G. A., Russell, M. W., and Cornelissen, C. N. (2005). Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect. Immun. 73, 3945-2953.
83. Pulendran, B., Li, S., and Nakaya, H. I. (2010). Systems vaccinology. Immunity 33, 516-529.
84. Ram, S., Mcquillen, D. P., Gulati, S., Elkins, C., Pangburn, M. K., and Rice, P. A. (1998). Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J. Exp. Med. 188, 671-680.
85. Ramsey, K. H., Schneider, H., Cross, A. S., Boslego, J. W., Hoover, D. L., Staley, T. L., Kuschner, R. A., and Deal, C. D. (1995). Inflammatory cytokines produced in response to experimental human gonorrhea. J. Infect. Dis. 172, 186-191.
86. Rechner, C., Kuhlewein, C., Muller, A., Schild, H., and Rudel, T. (2007). Host glycoprotein Gp96 and scavenger receptor SREC interact with PorB of disseminating Neisseria gonorrhoeae in an epithelial invasion pathway. Cell Host Microbe 2, 393-403.
87. Rice, P. A., McQuillen, D. P., Gulati, S., Jani, D. B., Wetzler, L. M., Blake, M. S., and Gotschlich, E. C. (1974). Serum resistance of Neisseria gonorhoeae. Does it thwart the inflammatory response and facilitate the transmission of infection? Ann. N. Y. Acad. Sci. 730, 7-14.
88. Rudel, T., Kepp, O., and Kozjak-Pavlovic, V. (2010). Interactions between bacterial pathogens and the mitochondrial cell death pathways. Nat. Rev. Microbiol.8, 693-705.
89. Schmidt, K. A., Schneider, H., Lindstrom, J. A., Boslego, J. W., Warren, R. A., Van de Berg, L., Deal, C. D., Mcclain, J. B., and Griffiss, J. M. (2001). Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers. Sex. Transm. Dis. 28, 555-564.
90. Schultz, T. R., Tapsall, J. W., and White, P. A. (2001). Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC. Antimicrob. Agents Chemother. 45, 734-738.
91. Seder, R., Darrah, P. A., and Roederer, M. (2008). T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8, 247-258.
92. Serino, L., Nesta, B., Leuzzi, R., Fontana, M. R., Monaci, E., Mocca, B. T., Cartocci, E., Masignani, V., Jerse, A. E., Rappuoli, R., and Pizza, M. (2007). Identification of a new OmpAlike protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization. Mol. Microbiol. 64, 1391-1403.
93. Simons, M. P., Nauseef, W. M., and Apicella, M. A. (2005). The interactions of Neisseria gonorrhoeae with adherent polymorphonuclear leukocytes. Infect. Immun. 73, 1971-1977.
94. Simons, M. P., Nauseef, W. M., Griffith, T. S., and Apicella, M. A. (2006). Neisseria gonorrhoeae delays the onset of apoptosis in polymorphonuclear leukocytes. Cell. Microbiol. 8, 1780-1790.
95. Snape, M. D., Dawson. T., Oster, P., Evans, A., John, T. M., Ohene-Kena, B. Findlow, J., Yu, L. M., Borrow, R., Ypma, E., Toneatto, D., and Pollard, A. J. (2010). Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Pediatr. Infect. Dis. J. 11, e71-e79.
96. Song,W.,Condron, S., Mocca, B. T.,Veit, S. J., Hill, D., Abbas, A., and Jerse, A. E. (2008). Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17 betaestradiol-treated mice. Vaccine 26, 5741-5751.
97. Sparling, P. F., Thomas C. E., and Zhu, W. (2003)."A vaccine for gonorrhea," in Bacterial Vaccines, eds R. W. Ellis and R. W. Brodeur (Georgetown, TX: Landes Bioscience), 128-154.
98. Tapchaisri, P., and Srinisinha, S. (1976). Serum and secretory antibody responses to Neisseria gonorrhoeae in patients with gonococcal infections. Brit. J. Vener. Dis. 52, 374-380.
99. Thomas, C. E., Zhu, W., Van Dam, C. N., Davis, N. L., Johnston, R. E., and Sparling, P. F. (2006). Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan encephalitis viral replicon particles. Infect. Immun. 74, 1612-1620.
100. Thompson, J. M., Whitmore, A. C., Konopka, J. L., Collier, M. L., Richmond, E. M. B., Davis, N. L., Staats, H. F., and Johnston, R. E. (2006). Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc. Natl. Acad. Sci. 103, 3722-3727.
101. Thompson, J. M., Whitmore, A. C., Staats, H. F., and Johnston, R. E. (2008a). The contribution of type I interferon signaling to immunity induced by alphavirus replion vaccines. Vaccine 26, 4998-5003.
102. Thompson, J. M., Whitmore, A. C., Staats, H. F., and Johnston, R. E. (2008b). Alpha virus replicon particles acting as adjuvants promote CD8+ T cell responses to codelivered antigen. Vaccine 26, 4267- 4275.
103. Tonkin, D. R., Jocquera, P., Todd, T., Beard, C. W., Johnston, R. E., and Barro, M. (2010). Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate immune response generated by primary immunization. Vaccine 28, s3238-s3246.
104. Tramont, E. C., and Boslego, J. W. (1985). Pilus vaccines. Vaccine 3, 3-10.
105. Ufret-Vincenty, R. L., Aredo, B., Liu, X., McMahan, A., Chen, P. W., Sun, H., Niederkorn, J. Y., and Kedzierski, W. (2010). Transgenic mice expressing variants of complement factor H develop AMD-like retinal findngs. Invest. Ophthalmol. Vis. Sci. 11, 5878-5887.
106. Virji, M. (2009). Pathogenic neisseria: surface modulation, pathogenesis and infection control. Nat. Rev. Microbiol. 7, 274-286.
107. Virji, M., Zak, K., and Heckels, J. E. (1986). Monoclonal antibodies to gonococcal membrane protein 1B; use in investigation of the potential protective effect of antibodies directed against conserved and typespecific epitopes. J. Gen. Microbiol. 132, 1621-1629.
108. Warner, D. M., Shafer, W. M., and Jerse, A. E. (2008). Clinically relevant mutations that cause derepression of the Neisseria gonorhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol. Microbiol. 70, 462-478.
109. Weel, J. F. L., and Putten, J. P. M. (1991). Fate of the major outer membrane protein P.1A in early and late events of gonococcal infection of epithelial cells. Res. Microbiol. 142, 985-993.
110. Welsch, J. A., and Ram, S. (2008). Factor H and Neisserial pathogenesis. Vaccine 8S, 140-145.
111. Wetzler, L. M. (2010). Innate immune functions of the neisserial porins and the relationship to vaccine adjuvant activity. Future Microbiol. 5, 749-758.
112. Wu, H., and Jerse, A. E. (2006). Sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. Infect. Immun. 74, 4094-4103.
113. Yamasaki, R., Koshino, H., Kurono, S., Nishinaka, Y., McQuillen, D. P., Kume, A., Gulati, S., and Rice, P. A. (1999). Structural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipooligosaccharides in spite of presence of human carbohydrate epitopes. J. Biol. Chem. 51, 36550-36558.
114. Zhang, L., Kovalev, G. I., and Su, L. (2007). HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 109, 2978-2981.
115. Zhu, W., Thomas, C. E., Chen, C. -J.,Van Dam, C. N., Johnston, R. E., Davis, N. L., and Sparling, P. F. (2005). Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis viral replicon particles. Infect. Immun. 73, 7558-7568.
116. Zhu, W., Thomas, C. E., and Sparling, P. F. (2004). DNA Immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine 22, 660-669.